Landmark Gene Therapy Slows Huntington’s Disease by 75 Percent

THE GUARDIAN

In a major clinical trial, gene therapy cut the progression of Huntington’s disease by three-quarters over three years. The treatment marks the first successful intervention for this genetic condition, giving patients and families a new path toward longer and healthier lives.